 |
市場調査レポート
商品コード
1461494
末梢血管装置の世界市場規模、シェア、成長分析、製品タイプ別、用途別、エンドユーザー別-産業予測、2024～2031年Global Peripheral Vascular Devices Market Size, Share, Growth Analysis, By Product Type, By Application(Peripheral artery disease, deep vein thrombosis ), By End user - Industry Forecast 2024-2031 |
||||||
| 末梢血管装置の世界市場規模、シェア、成長分析、製品タイプ別、用途別、エンドユーザー別-産業予測、2024～2031年 |
|
出版日: 2024年04月01日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
末梢血管装置の世界市場規模は2022年に108億6,000万米ドルと評価され、2023年の114億5,000万米ドルから2031年には174億3,000万米ドルに成長し、予測期間中（2024～2031年）のCAGRは5.4%で成長する展望です。
末梢血管疾患の診断と治療に使用される医療装置の開拓、生産、流通はすべて、ダイナミックで急速に拡大する末梢血管装置の世界市場に含まれています。静脈瘤、深部静脈血栓症、末梢動脈疾患（PAD）などの様々な病気を治療することで、この業界は患者の予後改善に大きく貢献しています。高齢化と血管障害の有病率の増加により、最先端で効率的な末梢血管装置に対するニーズは世界的に高まっています。末梢血管装置市場は、血管疾患の診断と治療のための最先端の装置と技術を医療従事者に提供するために存在しています。
目次
エグゼクティブサマリー
- 市場概要
- 繁栄と衰退
調査手法
- 情報調達
- 二次データソースと一次データソース
- 市場規模の推定
- 市場の危機と限界
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資の分析
- 主要成功要因
- 競合の程度
市場力学と展望
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
末梢血管装置の世界市場：製品タイプ別
- 市場概要
- 血管形成術用バルーン
- ステント
- 塞栓防止装置
- 末梢血管カテーテル
- アテローム切除装置
- 血管閉鎖装置
末梢血管装置の世界市場：用途別
- 市場概要
- 末梢動脈疾患（PAD）
- 深部静脈血栓症（DVT）
- 静脈瘤
- 動静脈瘻
末梢血管装置の世界市場：エンドユーザー別
- 市場概要
- 病院
- 外来手術センター
- 専門クリニック
末梢血管装置の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主要市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Medtronic（米国）
- Boston Scientific Corporation（米国）
- Abbott Laboratories（米国）
- Cook Medical（米国）
- Cordis Corporation（米国）
- Terumo Corporation（日本）
- Becton, Dickinson and Company（米国）
- Johnson & Johnson（米国）
- C.R. Bard（米国）
- Cardinal Health（米国）
- AngioDynamics（米国）
- Penumbra, Inc.（米国）
- W. L. Gore & Associates（米国）
- Endologix（米国）
- MicroPort Scientific Corporation（中国）
- BTG plc（英国）
- Spectranetics Corporation（米国）
- Teleflex Incorporated（米国）
- Edwards Lifesciences Corporation（米国）
- Lombard Medical Technologies（英国）
Global Peripheral Vascular Devices Market size was valued at USD 10.86 billion in 2022 and is poised to grow from USD 11.45 billion in 2023 to USD 17.43 billion by 2031, growing at a CAGR of 5.4% during the forecast period (2024-2031).
The development, production, and distribution of medical devices used in the diagnosis and treatment of peripheral vascular illnesses are all included in the dynamic and quickly expanding global market for peripheral vascular devices. By treating a variety of ailments such varicose veins, deep vein thrombosis, and peripheral artery disease (PAD), this industry significantly contributes to better patient outcomes. The need for cutting-edge and efficient peripheral vascular devices is growing globally due to an aging population and an increase in the prevalence of vascular disorders. The peripheral vascular devices market exists to give medical practitioners cutting-edge instruments and technologies for the diagnosis and treatment of vascular diseases.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Peripheral Vascular Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Peripheral Vascular Devices Market Segmental Analysis
Global Peripheral Vascular Devices Market is segmented on the basis of product type, application, end user, and region. By product type, the market is segmented into angioplasty balloons, stents, embolic protection devices, peripheral vascular catheters, atherectomy devices, and vascular closure devices. By application, the market is segmented into peripheral artery disease (PAD), deep vein thrombosis (DVT), varicose veins, and arteriovenous fistulas. By end user, the market is segmented into hospitals, ambulatory surgical centers, and specialty clinics. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Peripheral Vascular Devices Market
One major factor propelling the peripheral vascular devices market is the increasing incidence of cardiovascular disorders, including deep vein thrombosis (DVT) and peripheral artery disease (PAD). The World Health Organization (WHO) states that heart disease is the primary cause of death globally. The need for peripheral vascular devices for detection and treatment is rising as a result of the rising prevalence of cardiovascular illnesses.
Restraints in the Global Peripheral Vascular Devices Market
One major barrier to commercial expansion for peripheral vascular devices is their high cost. The cost of research and development, legal regulations, and the use of cutting-edge materials and technologies are just a few of the reasons why these gadgets can be costly. These devices' high price may prevent them from being widely used, especially in poor nations with tight healthcare budgets and difficult reimbursement policies.
Market Trends of the Global Peripheral Vascular Devices Market
Drug-eluting devices are becoming more and more popular in the peripheral vascular devices market. By delivering therapeutic medications straight to the damaged blood arteries, these devices help avoid restenosis (re-narrowing) and lessen the need for repeated procedures. Drug-eluting stents, for instance, improve patients' long-term outcomes by releasing anti-proliferative medications to prevent the formation of scar tissue in the artery.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Peripheral Vascular Devices Market by Product Type
- Market Overview
- Angioplasty balloons
- stents
- embolic protection devices
- peripheral vascular catheters
- atherectomy devices
- and vascular closure devices
Global Peripheral Vascular Devices Market by Application
- Market Overview
- Peripheral artery disease (PAD)
- deep vein thrombosis (DVT)
- varicose veins
- and arteriovenous fistulas.
Global Peripheral Vascular Devices Market by End user
- Market Overview
- Hospitals
- ambulatory surgical centers
- and specialty clinics
Global Peripheral Vascular Devices Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cook Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cordis Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- C.R. Bard (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardinal Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AngioDynamics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Penumbra, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- W. L. Gore & Associates (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Endologix (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BTG plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Spectranetics Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teleflex Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Edwards Lifesciences Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lombard Medical Technologies (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
